CLINICAL_TRIALS
trial_result
· 2025-02-27
Clinical Trial Update: Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia [Phase 1, Phase 2]
Summary
A Phase 1/2 pilot trial evaluating a single-dose Ilofotase alfa for hypophosphatasia has completed, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AM-Pharma | Conditions: Hypophosphatasia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-27